Orthovita gets Nasdaq listing but stays with Easdaq:
This article was originally published in Clinica
Executive Summary
Orthovita, an orthopaedic biomaterials company, has gone onto the Nasdaq US high technology market in addition to its listing on the European Easdaq. The shares opened at $6.50 before sliding down by around $1. The Malvern, Pennsylvania-based company is looking to broaden its US investor base while maintaining its European investors. The company plans a European launch of its VITOSS Scaffold cancellous bone resorbable calcium phosphate product in Europe next month.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.